Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease

BMC Veterinary Research

Table 4 ST2 concentrations in ng/mL for the respective groups at baseline and follow-up examination

Groups	Baseline (n; median [IQR])	Follow-up (n; median [IQR])	P-value
Control	20; 1.67 [0.64–1.96]	17; 1.68 [0.72–2.12]	0.0413*
Stage B1	38; 1.87 [0.99–2.16]	32; 1.91 [1.12–2.46]	0.0007**
Stage B2	9; 1.44 [0.31–2.12]	12; 1.68 [1.19–1.88]	NS
Stage C	14; 1.69 [1.28–1.99]	7; 1.62 [0.67–1.82]	NS

IQR Interquartile range, NS Non-significant. The p-value denotes the probability of the change in ST2 concentrations from baseline to follow-up examination for each group. Data are presented as median (interquartile range). * p < 0.05, ** p < 0.001

ISSN: 1746-6148